Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Income from Continuing Operations (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Income from Continuing Operations for 16 consecutive years, with 6662000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 162.81% to 6662000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 17556000.0, a 67.69% decrease, with the full-year FY2024 number at 42060000.0, down 34.06% from a year prior.
  • Income from Continuing Operations was 6662000.0 for Q3 2025 at Usana Health Sciences, down from 10444000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 40350000.0 in Q4 2021 to a low of 6662000.0 in Q3 2025.
  • A 5-year average of 17328263.16 and a median of 16537000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: soared 36.66% in 2021, then plummeted 162.81% in 2025.
  • Usana Health Sciences' Income from Continuing Operations stood at 40350000.0 in 2021, then tumbled by 68.29% to 12795000.0 in 2022, then soared by 31.04% to 16766000.0 in 2023, then plummeted by 73.26% to 4484000.0 in 2024, then tumbled by 248.57% to 6662000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Income from Continuing Operations are 6662000.0 (Q3 2025), 10444000.0 (Q2 2025), and 9290000.0 (Q1 2025).